Franklin's most recent trade in Royal Caribbean Group was a trade of 870 Common Stock done . Disclosure was reported to the exchange on May 28, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Royal Caribbean Group | John Franklin Brock | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 870 | 27,200 (0%) | 0% | 0 | Common Stock | |
SiriusPoint Ltd | Franklin Montross | Director | Grant, award, or other acquisition of securities at price $ 18.44 per share. | 27 May 2025 | 7,456 | 103,279 (0%) | 0% | 18.4 | 137,489 | Common Shares |
TTM Technologies Inc | Philip G. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2025 | 7,080 | 154,914 (0%) | 0% | 0 | Common Stock | |
Genpact Ltd | Tamara S. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 4,825 | 24,986 (0%) | 0% | 0 | Common Shares | |
XOMA Corp | Heather L. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 5,971 | 5,971 (0%) | 0% | 0 | Common Stock | |
Comfort Systems USA, Inc. | Franklin Myers | Director, CHAIRMAN OF THE BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 342 | 105,493 (0%) | 0% | 0 | Common Stock | |
Ally Financial Inc | Franklin W. Hobbs | Director | Grant, award, or other acquisition of securities at price $ 35.75 per share. | 15 May 2025 | 7,203 | 144,806 (0%) | 0% | 35.7 | 257,507 | Common Stock |
Minerals Technologies, Inc. | Franklin Lee Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 2,500 | 22,127 | - | - | PHANTOM STOCK UNITS | |
Escalade, Inc. | Katherine F. Franklin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2025 | 2,650 | 0 | - | - | Restricted Stock Units | |
Escalade, Inc. | Katherine F. Franklin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2025 | 2,650 | 30,579 (0%) | 0% | - | Common Stock | |
Escalade, Inc. | Katherine F. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 4,500 | 4,500 | - | - | Restricted Stock Units | |
Escalade, Inc. | Katherine F. Franklin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2025 | 2,150 | 2,150 | - | - | Restricted Stock Units | |
Escalade, Inc. | Katherine F. Franklin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2025 | 2,150 | 27,929 (0%) | 0% | - | Common Stock | |
Comfort Systems USA, Inc. | Franklin Myers | Director, CHAIRMAN OF THE BOARD | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2025 | 1,000 | 105,498 (0%) | 0% | 0 | Common Stock | |
Comfort Systems USA, Inc. | Franklin Myers | Director, CHAIRMAN OF THE BOARD | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2025 | 300 | 105,198 (0%) | 0% | 0 | Common Stock | |
Comfort Systems USA, Inc. | Franklin Myers | Director, CHAIRMAN OF THE BOARD | Gift of securities by or to the insider at price $ 0.00 per share. | 06 May 2025 | 47 | 105,151 (0%) | 0% | 0 | Common Stock | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.19 per share. | 02 May 2025 | 11,448 | 913,795 (2%) | 0% | 15.2 | 173,917 | Common Stock |
Centerpoint Energy Inc. | Christopher H. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 4,534 | 21,002 (0%) | 0% | 0 | Common Stock | |
Community Trust Bancorp, Inc. | Franklin H. Farris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Apr 2025 | 412 | 412 (0%) | 0% | 0 | Common Stock | |
Cass Information Systems Inc | Franklin D. Wicks | Director | Grant, award, or other acquisition of securities at price $ 39.48 per share. | 17 Apr 2025 | 2,026 | 31,110 (0%) | 0% | 39.5 | 79,986 | Common Stock |
CTO Realty Growth Inc - Or... | Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 18.95 per share. | 01 Apr 2025 | 659 | 55,155 (1%) | 0% | 18.9 | 12,487 | Common Stock |
Minerals Technologies, Inc. | Franklin Lee Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 195 | 19,627 | - | - | PHANTOM STOCK UNITS | |
Midland States Bancorp Inc | Travis J. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 700 | 4,283 | - | - | Common Share Equivalent | |
Midland States Bancorp Inc | Travis J. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 56 | 3,582 | - | - | Common Share Equivalent | |
Foot Locker Inc | Franklin R. Bracken | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.27 per share. | 27 Mar 2025 | 4,213 | 221,772 (0%) | 0% | 15.3 | 64,333 | Common Stock |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.56 per share. | 24 Mar 2025 | 2,171 | 925,243 (2%) | 0% | 17.6 | 38,131 | Common Stock |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.52 per share. | 24 Mar 2025 | 1,500 | 927,414 (2%) | 0% | 17.5 | 26,282 | Common Stock |
Foot Locker Inc | Franklin R. Bracken | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2025 | 85,777 | 225,985 (0%) | 0% | 0 | Common Stock | |
Foot Locker Inc | Franklin R. Bracken | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.13 per share. | 23 Mar 2025 | 3,264 | 140,208 (0%) | 0% | 16.1 | 52,648 | Common Stock |
Cass Information Systems Inc | Franklin D. Wicks | Director | Grant, award, or other acquisition of securities at price $ 43.70 per share. | 20 Mar 2025 | 297 | 29,084 (0%) | 0% | 43.7 | 12,979 | Common Stock |
Element Solutions Inc | Martin E. Franklin | Director | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 19 Mar 2025 | 1,609,100 | 5,280,413 (2%) | 0% | 26.1 | 41,997,510 | Common Stock, par value $0.01 per share |
Element Solutions Inc | Martin E. Franklin | Director | Sale of securities on an exchange or to another person at price $ 26.10 per share. | 19 Mar 2025 | 390,900 | 109,100 (0%) | 0% | 26.1 | 10,202,490 | Common Stock, par value $0.01 per share |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 17.61 per share. | 17 Mar 2025 | 1,200 | 928,914 (2%) | 0% | 17.6 | 21,137 | Common Stock |
Essential Utilities Inc | Christopher H. Franklin | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 39.40 per share. | 14 Mar 2025 | 7,700 | 32,228 (0%) | 0% | 39.4 | 303,380 | Common Stock 401k |
Atmos Energy Corp. | Franklin H. Yoho | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 1,082 | 8,211 | - | - | Phantom Stock Units | |
Minerals Technologies, Inc. | Franklin Lee Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 31 | 19,431 | - | - | PHANTOM STOCK UNITS | |
Mueller Water Products Inc... | Shirley Clarke Franklin | Former Director | Sale of securities on an exchange or to another person at price $ 24.67 per share. | 05 Mar 2025 | 7,376 | 65,043 (0%) | 0% | 24.7 | 181,995 | Common Stock |
Stellar Bancorp Inc | Robert R. Franklin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 29,552 | 425,916 (1%) | 0% | 0 | Common Stock | |
Stellar Bancorp Inc | Robert R. Franklin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 14,266 | 396,364 (1%) | 0% | 0 | Common Stock | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 396,000 | 396,000 | - | - | Stock Option (right to buy) | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 151,000 | 955,129 (2%) | 0% | 0 | Common Stock | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.03 per share. | 28 Feb 2025 | 20,880 | 934,249 (2%) | 0% | 13.0 | 272,089 | Common Stock |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 13.28 per share. | 28 Feb 2025 | 4,135 | 930,114 (2%) | 0% | 13.3 | 54,930 | Common Stock |
HF Sinclair Corporation | Franklin Myers | Director | Purchase of securities on an exchange or from another person at price $ 35.66 per share. | 26 Feb 2025 | 5,000 | 154,065 (0%) | 0% | 35.7 | 178,314 | Common Stock |
Mueller Water Products Inc... | Shirley Clarke Franklin | Director | Sale of securities on an exchange or to another person at price $ 25.11 per share. | 24 Feb 2025 | 8,825 | 72,419 (0%) | 0% | 25.1 | 221,556 | Common Stock |
Stellar Bancorp Inc | Robert R. Franklin | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Feb 2025 | 31,880 | 382,098 (1%) | 0% | 0 | Common Stock | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 3,310 | 3,310 | - | - | Performance Share Units | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 2,640 | 2,640 | - | - | Stock Appreciation Right | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 1,100 | 1,100 | - | - | Restricted Stock Units | |
Easterly Government Proper... | Franklin V. Logan | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2025 | 864 | 864 | - | - | LTIP Units | |
Essential Utilities Inc | Christopher H. Franklin | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 29,539 | 276,744 (0%) | 0% | 0 | Common Stock | |
Essential Utilities Inc | Christopher H. Franklin | Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.65 per share. | 18 Feb 2025 | 19,022 | 257,722 (0%) | 0% | 35.6 | 678,134 | Common Stock |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,100 | 8,755 (0%) | 0% | - | Common Stock | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,100 | 0 | - | - | Common Stock (Restricted Stock Units) | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.76 per share. | 18 Feb 2025 | 471 | 8,284 (0%) | 0% | 272.8 | 128,470 | Common Stock |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,764 | 10,236 (0%) | 0% | - | Common Stock | |
Kezar Life Sciences Inc | John Franklin Fowler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 3,200 | 0 | - | - | Performance Share Units | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 269.33 per share. | 14 Feb 2025 | 2,581 | 7,655 (0%) | 0% | 269.3 | 695,141 | Common Stock |
CTO Realty Growth Inc - Or... | Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.62 per share. | 12 Feb 2025 | 3,185 | 54,353 (1%) | 0% | 19.6 | 62,483 | Common Stock |
First Financial Corp. - In... | Mark A. Franklin | CHIEF LENDING OFFICER | Sale of securities on an exchange or to another person at price $ 51.71 per share. | 12 Feb 2025 | 1,100 | 8,745 (0%) | 0% | 51.7 | 56,881 | First Financial Corp Stock |
First Financial Corp. - In... | Mark A. Franklin | CHIEF LENDING OFFICER | Purchase of securities on an exchange or from another person at price $ 52.53 per share. | 12 Feb 2025 | 1,100 | 9,845 (0%) | 0% | 52.5 | 57,783 | First Financial Corp Stock |
Dominari Holdings Inc | Christopher Franklin Devall | COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 351,851 | 410,702 (8%) | 7% | - | Common Stock | |
Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 28,818 | - | - | Series B Warrants (right to buy) | |
Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 58,851 (1%) | 0% | - | Common Stock | |
Dominari Holdings Inc | Christopher Franklin Devall | COO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Feb 2025 | 28,818 | 28,818 | - | - | Series A Warrants (right to buy) | |
Mueller Water Products Inc... | Shirley Clarke Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 4,672 | 12,048 | - | 0 | Restricted Stock Unit | |
Essential Utilities Inc | Christopher H. Franklin | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 39,855 | 286,902 (0%) | 0% | 0 | Common Stock | |
Essential Utilities Inc | Christopher H. Franklin | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2025 | 39,855 | 286,902 (0%) | 0% | 0 | Common Stock | |
First Financial Corp. - In... | Mark A. Franklin | CHIEF LENDING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2025 | 2,444 | 8,745 (0%) | 0% | 0 | First Financial Corp Stock | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 12.70 per share. | 03 Feb 2025 | 19,301 | 804,129 (2%) | 0% | 12.7 | 245,123 | Common Stock |
Atea Pharmaceuticals Inc | Franklin M. Berger | Director | Purchase of securities on an exchange or from another person at price $ 3.19 per share. | 15 Jan 2025 | 15,000 | 466,897 | - | 3.2 | 47,885 | Common Stock |
Atea Pharmaceuticals Inc | Franklin M. Berger | Director | Purchase of securities on an exchange or from another person at price $ 3.36 per share. | 15 Jan 2025 | 10,000 | 476,897 | - | 3.4 | 33,614 | Common Stock |
Easterly Government Proper... | Franklin V. Logan | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 11,405 | 11,405 | - | - | LTIP Units | |
Easterly Government Proper... | Franklin V. Logan | EVP, GC & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 3,919 | 3,919 | - | - | LTIP Units | |
First Financial Corp. - In... | Mark A. Franklin | CHIEF LENDING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.19 per share. | 02 Jan 2025 | 784 | 5,999 (0%) | 0% | 46.2 | 36,213 | First Financial Corp Stock |
CTO Realty Growth Inc - Or... | Laura M. Franklin | Director | Grant, award, or other acquisition of securities at price $ 19.98 per share. | 02 Jan 2025 | 625 | 51,168 (1%) | 0% | 20.0 | 12,488 | Common Stock |
Minerals Technologies, Inc. | Franklin Lee Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 162 | 19,400 | - | - | PHANTOM STOCK UNITS | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 1,353,962 | 1,357,695 | - | 0 | Common Stock | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 978,958 | 14,045,860 | - | 0 | Common Stock | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 978,958 | 372,409 | - | 0 | Common Stock | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 362,241 | 10,168 | - | 0 | Common Stock | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 362,241 | 362,241 | - | 0 | Common Stock | |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Other type of transaction at price $ 36.65 per share. | 31 Dec 2024 | 6,328 | 1,351,367 | - | 36.6 | 231,921 | Common Stock |
Midland States Bancorp Inc | J. Travis Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 491 | 3,526 | - | - | Common Share Equivalent | |
Wheeler Real Estate Invest... | M. Andrew Franklin | CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 67 | 505 | - | - | Series D Cumulative Convertible Preferred Stock | |
Midland States Bancorp Inc | Travis J. Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 35 | 3,034 | - | - | Common Share Equivalent | |
Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 15.17 per share. | 20 Dec 2024 | 15,000 | 823,430 (2%) | 0% | 15.2 | 227,567 | Common Stock |
Cass Information Systems Inc | D. Wicks Franklin | Director | Grant, award, or other acquisition of securities at price $ 42.26 per share. | 19 Dec 2024 | 307 | 28,787 (0%) | 0% | 42.3 | 12,974 | Common Stock |
Atea Pharmaceuticals Inc | M. Berger Franklin | Director | Sale of securities on an exchange or to another person at price $ 2.85 per share. | 10 Dec 2024 | 359,606 | 451,897 | - | 2.8 | 1,023,475 | Common Stock |
Minerals Technologies, Inc. | Franklin L. Feder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 26 | 19,237 | - | - | PHANTOM STOCK UNITS | |
Pagerduty Inc | Sarah Joyce Franklin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 20,871 | 20,871 (0%) | 0% | 0 | Common Stock | |
Kennametal Inc. | Franklin Cardenas | Vice President | Sale of securities on an exchange or to another person at price $ 28.24 per share. | 04 Dec 2024 | 20,470 | 39,581 (0%) | 0% | 28.2 | 578,052 | Common Stock |
Foot Locker Inc | Franklin R. Bracken | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.60 per share. | 16 Nov 2024 | 2,846 | 143,472 (0%) | 0% | 23.6 | 67,166 | Common Stock |
APi Group Corporation | Martin E. Franklin | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Nov 2024 | 380,000 | 13,066,902 | - | 0 | Common Stock | |
HF Sinclair Corporation | Franklin Myers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 3,772 | 149,065 (0%) | 0% | 0 | Common Stock | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 3,900 | 0 | - | - | Stock Appreciation Right | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 133.95 per share. | 08 Nov 2024 | 3,900 | 9,764 (0%) | 0% | 134.0 | 522,405 | Common Stock |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 164.38 per share. | 08 Nov 2024 | 3,200 | 8,595 (0%) | 0% | 164.4 | 526,016 | Common Stock |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Nov 2024 | 3,200 | 0 | - | - | Stock Appreciation Right | |
Vulcan Materials Co | Denson N. Franklin | SVP, Gen. Counsel & Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 290.59 per share. | 08 Nov 2024 | 2,731 | 5,864 (0%) | 0% | 290.6 | 793,601 | Common Stock |